% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schmidt:285365,
author = {M. Schmidt$^*$ and T. Maurer and S. Behrens$^*$ and P.
Seibold$^*$ and N. Obi and J. Chang-Claude$^*$ and K.
Steindorf$^*$},
title = {{C}ancer-related fatigue: {T}owards a more targeted
approach based on classification by biomarkers and
psychological factors.},
journal = {International journal of cancer},
volume = {154},
number = {6},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2023-02334},
pages = {1011-1018},
year = {2024},
note = {#EA:C110#LA:C110# / 2024 Mar 15;154(6):1011-1018},
abstract = {Cancer-related fatigue is a frequent, burdensome and often
insufficiently treated symptom. A more targeted treatment of
fatigue is urgently needed. Therefore, we examined
biomarkers and clinical factors to identify fatigue subtypes
with potentially different pathophysiologies. The study
population comprised disease-free breast cancer survivors of
a German population-based case-control study who were
re-assessed on average 6 (FU1, n = 1871) and 11 years (FU2,
n = 1295) after diagnosis. At FU1 and FU2, we assessed
fatigue with the 20-item multidimensional Fatigue Assessment
Questionnaire and further factors by structured
telephone-interviews. Serum samples collected at FU1 were
analyzed for IL-1ß, IL-2, IL-4, IL-6, IL-10, TNF-a, GM-CSF,
IL-5, VEGF-A, SAA, CRP, VCAM-1, ICAM-1, leptin, adiponectin
and resistin. Exploratory cluster analyses among survivors
with fatigue at FU1 and no history of depression yielded
three clusters (CL1, CL2 and CL3). CL1 (n = 195) on average
had high levels of TNF-α, IL1-β, IL-6, resistin, VEGF-A
and GM-CSF, and showed high BMI and pain levels. Fatigue in
CL1 manifested rather in physical dimensions. Contrarily,
CL2 (n = 78) was characterized by high leptin level and had
highest cognitive fatigue. CL3 (n = 318) did not show any
prominent characteristics. Fatigued survivors with a history
of depression (n = 214) had significantly higher physical,
emotional and cognitive fatigue and showed significantly
less amelioration of fatigue from FU1 to FU2 than survivors
without depression. In conclusion, from the broad phenotype
'cancer-related fatigue' we were able to delineate subgroups
characterized by biomarkers or history of depression. Future
investigations may take these subtypes into account,
ultimately enabling a better targeted therapy of fatigue.},
keywords = {breast cancer (Other) / cancer survivorship care (Other) /
fatigue (Other) / inflammation (Other) / patient-reported
outcomes (Other)},
cin = {C110 / C020},
ddc = {610},
cid = {I:(DE-He78)C110-20160331 / I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37950650},
doi = {10.1002/ijc.34791},
url = {https://inrepo02.dkfz.de/record/285365},
}